Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

METHYS Dx

METHYS Dx develops methylation marker panels for ctDNA characterization in liquid biopsies, focusing on non-invasive cancer monitoring.
2021
11-50
Paris, Ile-de-France, France
BiopharmaBiotechnologynologyPrecision MedicineTest and Measurement

Investment Funding

Revenue

$1M to $10M